A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study

Clinical trial NCT05048849 · COMPLETED

Trial details

NCT number: NCT05048849
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-07-19
Primary completion: 2021-11-08
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.